About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Massachusetts | 508 Studies

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 508 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 461-480 of 508 trials

CompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerRandomized phase III trial to compare the effectiveness of low, intermediate, and high dose suramin in treating men with stage IV prostate cancer that is refractory to hormone…NCT00002723·Chicago, Illinois and 26 others RecruitingA Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestThis research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe…NCT05899361·Boston, Massachusetts

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerRATIONALE: Massage therapy may help relieve symptoms associated with cancer.NCT00253708·Boston, Massachusetts

RecruitingPilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide TetraxetanThe purpose of this research study is to see how well an imaging test, called 18FDCFPyL prostate specific membrane antigen (PSMA) positron emission tomography (PET), can show the…NCT06099093·Boston, Massachusetts and 1 other

CompletedCOMbination of Bipolar Androgen Therapy and NivolumabSingle arm, multicenter, open-label Phase II study of the effects of parenteral testosterone in combination with nivolumab in men with metastatic castration-resistant prostate…NCT03554317·San Francisco, California and 2 others

CompletedIpatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of ipatasertib plus abiraterone and prednisone/prednisolone compared with placebo plus…NCT03072238·Chandler, Arizona and 175 others

CompletedProspective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After SurgeryThe influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCRNCT02080689·Anchorage, Alaska and 18 others

CompletedRosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate CancerThe purpose of this study it to learn the effects (good or bad) that rosiglitazone has on patients and their prostate cancer.NCT00182052·Boston, Massachusetts and 1 other

CompletedMGD019 DART® Protein in Unresectable/Metastatic CancerThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) pharmacodynamics and preliminary antitumor activity of lorigerlimab.NCT03761017·Chicago, Illinois and 38 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

CompletedA Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…NCT02952534·Birmingham, Alabama and 148 others

CompletedProstate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyDutasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT) the male hormone that leads to benign prostate growth.NCT00470834·Homewood, Alabama and 61 others

TerminatedTivozanib + Enzalutamide in Adv Prostate CancerThis research study is a Phase II clinical trial, which tests the safety and effectiveness of an investigational combination of drugs to learn whether they work in treating a…NCT01885949·Boston, Massachusetts

CompletedWhole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate CancerThis phase 0 trial studies whole body fluorine F 18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) scan and whole body magnetic resonance imaging…NCT00956163·Boston, Massachusetts

TerminatedA 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerA Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.NCT01709734·Los Angeles, California and 22 others

TerminatedSafety of LBH589 Alone and in Combination With Intravenous Docetaxel and PrednisoneThis 2-arm study is designed to determine the maximum tolerated dose of LBH589 as a single agent and in combination with docetaxel and prednisone 5 mg twice daily (second arm) and…NCT00419536·Boston, Massachusetts and 2 others

Enrolling by invitationPilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate CancerIn this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in…NCT04399876·Boston, Massachusetts

CompletedSurgery in Treating Patients With Prostate CancerRATIONALE: Prostatectomy may be an effective treatment for prostate cancer that has not responded to radiation therapy.NCT00002938·Anniston, Alabama and 60 others

CompletedOpen-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisThe purpose of this trial with Zometa is to investigate the effect ZOMETA 4 mg (zoledronic acid for injection in 100mg solution ) has in preventing associated bone loss in…NCT00035997·Birmingham, Alabama and 55 others

PreviousPage 24 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma